Sign in Create account

Jupiter Life Line Hospitals Limited

Healthcare · Healthcare Services

NSE: JLHL BSE: 543980
₹253.60
▼ -8.45 (-3.22%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
68/100
Moderate
Valuation
99/100
Undervalued
Momentum
38/100
Neutral

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹1,663 Cr
PE (TTM)
9.0
Industry median 50.2 (44 companies)
Price to Book
1.1
PEG (TTM)
-8.3
Institutions holding %
25.88%
FII + DII, latest filed period
Piotroski Score
4
Relative return vs Nifty50, qtr %
-72.7
Relative return vs Sector, qtr %
-79.7
Free Cash Flow
₹-234 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
-14.09%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
-1.72%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
14.08%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
-14.10%
as of June 30, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
18.18%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
3.02
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.33
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
14.63
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
11.32%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
17.73%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
21.05%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
8.08%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
13.51%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
12.47%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 8 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 4)
  • Yes Debt to equity is below 0.5 (0.33)
  • No Return on equity is 15% or more (12.5%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

2 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Undervalued (below its own historical PE range))
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-3.2%
Low 251.5000 · High 263.0500
1W return
-7.5%
Low 251.5000 · High 275.0000
1M return
-14.2%
Low 251.5000 · High 299.0000
52W return
-83.1%
Low 251.5000 · High 1625.0000
Lifetime High ₹1698.5500 (March 25, 2025)
Lifetime Low ₹253.6000 (Sept. 30, 2026)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
262.1
10D
267.7
20D
285.8
50D
452.5
100D
705.1
200D
1079.8

Delivery and volume

Day avg. delivery
56.4%
Week avg. delivery
58.1%
Month avg. delivery
62.5%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

256.05
Pivot
First resistance260.60
Second resistance267.60
Third resistance272.15
First support249.05
Second support244.50
Third support237.50
Day RSI12.7
Day MFI11.9
Day MACD-39.13
Day MACD signal-50.47

Beta

1M0.67
3M1.07
1Y0.42
3Y0.45

Price change analysis

↓ -14.2%
Over 1 Month
LowHigh
251.50299.00
↓ -82.4%
Over 3 Months
LowHigh
251.501598.00
↓ -79.7%
Over 6 Months
LowHigh
251.501598.00
↓ -83.1%
Over 1 Year
LowHigh
251.501625.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 9.0 (own history: 43.9–56.7)
Undervalued (below its own historical PE range)

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹328 Cr
Net profit (June 30, 2026)
₹37 Cr
Basic EPS (June 30, 2026)
₹5.6700

Ranks #29 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter40.91%
  • Mutual funds10.89%
  • FII/FPI9.37%
  • Other DII5.62%
  • Public33.21%

Largest holders

NameCategoryShares %Shares
AJAY PRATAP THAKKERPromoter20.7400%13597829
WESTERN MEDICAL SOLUTIONS LLPPromoter8.7000%5703797
SBI HEALTHCARE OPPORTUNITIES FUNDPublic7.7700%5096817
ANKIT AJAY THAKKERPromoter6.6700%4375789
JM FINANCIAL PRODUCTS LIMITEDPublic3.4200%2240000

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 40.91% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 8.48% to 9.37% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings decreased from 10.97% to 10.89% in Jun 2026 qtr

10 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 0 insider trades, 4 SAST, 0 pledge events →

All insider and SAST disclosures →

Deals (Bulk & Block)

All 24 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
15 Jul 2026 HDFC MUTUAL FUND Block Buy 337,000 1483.5000 BSE
15 Jul 2026 ARVIND RAO RAO KAMINI Block Sell 337,000 1483.5000 BSE
15 Jul 2026 MITUL NITIN THAKKER Block Sell 600,000 1483.5000 BSE
15 Jul 2026 ARVIND RAO RAO KAMINI Bulk Sell 337,000 1483.5000 BSE
15 Jul 2026 MITUL NITIN THAKKER Bulk Sell 600,000 1483.5000 BSE
15 Jul 2026 HDFC MUTUAL FUND Bulk Buy 937,000 1483.5000 BSE
13 Nov 2025 SBI MUTUAL FUND Bulk Buy 2,313,615 1497.8000 NSE
13 Nov 2025 SBI MUTUAL FUND Bulk Sell 2,313,613 1497.8000 NSE
29 Aug 2024 THINK INDIA OPPORTUNITIES MASTER FUND LP Block Buy 200,000 1310.0000 NSE
29 Aug 2024 RAGHAVAN VADAPATRA SAYEE Block Sell 100,000 1310.0000 NSE

All bulk and block deals →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
31 Jul 2026 Financial Results Yes
15 May 2026 Financial Results Yes
30 Jan 2026 Financial Results Yes
7 Nov 2025 Financial Results Yes
1 Aug 2025 Financial Results Yes

Corporate Announcements

All 2 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
25 Sep 2026 Insider Trading / SAST Jupiter Life Line Hospitals Ltd - 543980 - Closure of Trading Window
15 Sep 2026 Company Update Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Comfortable interest coverage (14.6x)
  • Strong revenue growth YoY (18.2%)

Weaknesses

  • Declining profit YoY (-14.1%)

Opportunities

  • PE below 15 (9.0) relative to a typical growth business
  • RSI in oversold territory (12.7) -- a technical rebound zone

Threats

  • Down 83.1% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Jupiter Life Line Hospitals Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.